Role of a Central Laboratory in Implementing National Cholesterol Education Panel Guidelines in Rural Practices: Model System for Managed Care Roberta G. Reed,' Sophia V. Fong, and Thomas A. Pearson We describe the use of a central laboratory to identify patients who may be candidates for a hypercholesterolemia treatment program and to direct their referral into this program. The laboratory, providing service for 16 medical practices in a rural area of upstate New York, served as the entry point to the treatment program for those patients with serum cholesterol 5.18 mmol/L. This treatment program, designed to follow the National Cholesterol Education Program Adult Treatment Panel Guidelines, was provided by the lipid referral center staff, including a registered dietitian and a lipid specialist. After introduction of this program, 52% of eligible patients received nutritional counseling for hypercholesterolemia, compared with only 29% in usual care settings. This program represents an enhanced role for laboratories in the implementation of treatment protocols typical of those adopted by managed care networks.
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The well-documented association of hypercholesterolemia with coronary heart disease led the National Cholesterol Education Program (NCEP) to recommend, in 1988, strategies to reduce blood cholesterol concentrations in the US population (1 )2 One strategy, developed by the Adult Treatment Panel (ATP), provides specific recommendations for healthcare providers to identify and treat patients who would benefit most by reducing their cholesterol concentrations.
Recently, the extent of identification and treatment of high blood cholesterol was evaluated in a national survey of 154 735 adults. The conclusions of this survey, which reflected practices from 1988 to 1990, were that fewer than one-third of adults needing treatment for high blood cholesterol were actually receiving it (2) , that changes in physician behavior would be required to increase the treatment rates, and that such changes would be best effected by changes in healthcare delivery systems.
Delivery of preventive healthcare is particularly difficult. Barriers to accessing preventive services include limmted availability of ancillary healthcare professionals such as clinical nutritionists, inconvenience for patients to travel to clinic sites (often reflecting long distances or the absence of public transportation), and
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Fax 607-547-3061. were chosen by a randomization scheme appropriate for each clinic to ensure that representative patients were chosen. The audit covered the period from January 1988 to July 1990, the 30-month period after the promotion of the NCEP guidelines, and included demographic information, medical history, family history of coronary heart disease (CHD), presence of other CIII) Practices were split into two groups of eight-an intervention group and a usual care group. Assignment was designed to ensure that the two groups of clinics were as comparable as possible. Before assignment to one of the groups, clinics were paired on the basis of their size, numbers and types of practitioners, and overall aggressiveness of the clinic in identifying and treating hypercholesterolemia as reflected by the audit of the previous 30-month period. One member of each pair of clinics was then assigned by a randomization scheme to the intervention group. Characteristics of the two groups of clinics are shown in Table 1 .
Physicians, physician assistants, and nurse practitioners from these practices were offered educational sessions about the NCEP-ATP guidelines and the treatment of hypercholesterolemia. Those from usual care clinics were told that their patients might be recruited to be part of a study evaluating implementation of the NCEP guidelines.
Those in intervention clinics were offered a chance to refer their patients to a treatment program. The criteria for eligibility of patients was the same for both groups.
Patients from all 16 practices were identified on the basis of cholesterol measurement that had been ordered by their caregivers as part of routine care. The laboratory computer system was queried on a weekly basis to identify all patients from ages 18 to 70 who, on routine blood tests, had a blood cholesterol concentration 5.18 For each such patient, the patient's name, the medical record number, the clinic site, and the name of the ordering healthcare provider were transferred into a database designed to support the Lipid Resource Center program. The patient's name and medical record number were compared with the existing database for the program to classify the patient as new or previously identified. Fig. 1 ifiustrates schematically how the computer identification system functioned. When a patient with a serum cholesterol 5. 18 mmol/L was identified as new, the primary care provider was sent a two-part postcard indicating that the patient had recently had a cholesterol measurement. The providers at intervention clinics were reminded that the patient had a high cholesterol concentration and were offered a chance to refer the patient to the Lipid Resource Center for initiation of an AHA Step I diet. The providers in the usual care clinics were asked whether the patient was eligible for participation in a study of hypercholesterolemia, but were not offered a chance to enroll the patient in a treatment program. One part of the postcard indicating eligibility of the patient for treatment (intervention clinics) or inclusion in a study (usual care clinics) was returned to the Lipid Resource Center. If the patient was identified as not eligible, the provider was asked to identify any of several reasons for ineligibility. These included medical reasons (e.g., the presence of terminal disease), failure to meet NCEP-ATP criteria [e.g., a borderline cholesterol with no other risk factors, or a borderline total cholesterol with high high-density vided a toll-free phone number to call a registered dietitian; the dietitian also initiated calls to provide encouragement and feedback. Upon completion of the home-based educational program, the patient provided a 3-day diet record for evaluation by the dietitian. This record was used to determine the success of implementing an AHA Step I diet and the results were reported to the referring healthcare provider. In addition, a subset of randomly selected patients from each group was monitored at baseline and after 3, 6, and 9 months to collect additional dietary and medical information. Among the patients not eligible, the most frequent reasons for ineligibility were that the patient had already begun a treatment for hypercholesterolemia [either prescribed a cholesterol-lowering medication (10%) or referred to a nutritionist for a cholesterollowering diet (5%)] or that the patient did not warrant treatment because of a desirable HDIJLDL ratio or the lack of any risk factors other than moderately increased cholesterol concentration (5%). In the 30 months before the initiation of this program, the eight clinics that were randomized to be intervention clinics screened 60% of adult patients for 
cholesterol
( Table 1 ). The eight clinics that became usual care clinics screened 50% of adult patients for cholesterol. Although the intervention clinics appeared to have a slightly higher screening rate, the follow-up counseling and treatment was not significantly different in the two practices. Only 32-35% of patients who had cholesterol measured received any information or advice regarding follow-up. The percentages of patients with hypercholesterolemia receiving dietary counseling were likewise very similar.
During the 18 months of the rural Lipid Resource Center program, 1317 patients from the eight intervention clinics were referred for education and counseling on implementation of an AJIA Step I diet. At the same time a comparable group of 1404 patients were identified from the usual care clinics but were not referred for the intervention program.
Of the 1317 patients referred, 1299 (98.6%) responded and received the educational materials. Of those, 831 (63%) carried out part or all of the home video program and workbook. Table 2 summarizes the enrollment.
During the course of the intervention program, a random sample of patients was recruited from each practice (160 from intervention clinics and 144 from usual care clinics) and interviewed, and 3-day diet records were recorded at baseline, 3 months, 6 months, and 9 months. By 9 months, the patients in the intervention clinics had reduced their intake of calories as saturated fat and dietary cholesterol significantly more than those in usual care clinics (3). In addition, implementing this cholesterol-lowering program was no more costly than a traditional, usual care program (4). After completion of the 27-month trial (18-month enrollment period and 9-month follow-up) a second chart audit of the control and intervention clinics was carried out to assess the impact of the program. Fig. 3 compares the identification rates of hypercholesterolemia among screened patients and the dietary counseling rates for patients with cholesterol 5.18 mmol/L. Although both sets of clinics saw comparable percentages of patients with high cholesterol, the implementation and documentation of a dietary counseling program was significantly greater in the intervention clinics (52%) than in the usual care clinics (26%).
Discussion
The model of a central laboratory and lipid referral center was designed to assist primary care providers in The sharing of a central facility, such as the Lipid Resource Center described here, allows specialized care and service to be available to medical practices that are too small to maintain such a program by themselves. The laboratoryinitiated alert and referral postcards assured that primary care providers could access the program for their patients with minimal time and effort. The unique feature of the program is the lead role assumed by the laboratory in providing caregivers both notification that a condition exists that may require treatment and a simple mechanism to initiate that treatment. Thus, in this model the laboratory has a greater responsibility than in usual settings in assuring that all patients who might require some kind of treatment are both identified and referred to a treatment center.
Automatic notification from the laboratory to the primary care provider, including direct access for referral to the recommended follow-up care, is an excellent model for managed care. In managed care networks, a group practice adopts protocols for treatment and follow-up for specific types of patients meeting specific criteria. Efficiency is increased when a patient is identified and referred to the appropriate service in the most timely and cost-effective manner. We followed the NCEP-ATP guidelines as the model protocol. Using a simple computer-identification scheme to search for cholesterol 5.18 mmol/L and a postcard alert system increased the percentage of adults referred for care for hypercholesterolemia from 29% in usual care setting to 52% when the Lipid Resource Center program was available. Since the final chart audit included 30 months, of which only 18 included active use of the alert system to recruit patients into the program, 52% probably underestimates the number who would have been referred for care had the program been active for the entire 30-month period. On the basis of the response to the alert postcards during the 18-month period of recruitment, 98.6% of the patients identified as eligible were provided dietary counseling. Since 69% of patients with hypercholesterolemia were identified as eligible (2721 of 3948), we can estimate that -68% of eligible patients would be referred for and receive dietary counseling in an ongoing program.
In 1993, new guidelines from the NCEP (NCEP-ATP II) recommended either total cholesterol 5. 18 mmol/L or HDL <0.906 mmol/L as criteria for further evaluation (5) . This change in protocol for treatment of hypercholesterolemia could be conveniently incorporated in the laboratory computer identification system to assure that adults who meet the new criteria will be identified. The alert card would be reprinted with the additional information for eligibility for the protocol. Thus, the changes may be incorporated into practice by simple modifications to the existing system, minimizing the difficulty in implementing a protocol change across a managed care system with many care providers in many different sites.
As medical systems move increasingly to managed care models, laboratories will be afforded new opportunities to participate in developing integrated systems for improving healthcare delivery. The identification and referral program, as described here for hypercholesterolemia, represents one such opportunity.
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